Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;26(3):382-386.
doi: 10.1038/s41431-017-0067-1. Epub 2018 Jan 10.

Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers

Affiliations

Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers

Albert Grinshpun et al. Eur J Hum Genet. 2018 Mar.

Abstract

Mutations in the BRCA1/2 genes were recently shown to be associated with an increased risk for colorectal cancer. We characterized the largest cohort available of BRCA1/2 mutation carriers with colorectal cancer. We analyzed 32 patients with lower gastrointestinal cancers and germline BRCA1/2 mutations from two large academic hospital registries; 91% of patients were of Ashkenazi ancestry, 78% were women, and 62.5% were carriers of BRCA1 gene mutations. A high percentage of colorectal tumors (34.5%) had a mucinous histology and were located atypically in the left colon. Two patients had anal cancer with unusual histology and an additional patient had mucinous small bowel carcinoma. Gene expression analysis showed significant correlation between the gene signatures of left mucinous colorectal cancer and basal-like breast cancer. Our results imply that Ashkenazi BRCA1/2 mutation carriers with colorectal cancer might have unique characteristics with a high rate of left-sided, mucinous histology colorectal cancer, and possibly anal carcinoma. This report suggests a phenotypic influence of defects in DNA repair genes on colorectal tumors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Correlations with molecular signatures and the survival of right/left colorectal mucinous or non-mucinous adenocarcinoma tumors. a Boxplot showing the relative correlation of CRC types with the basal-like breast cancer PAM50 vector. Each box represents the second and third quartiles within each group; the center line marks the median and plus signs represent outliers. b Same analysis for the complete basal-like signature. c Kaplan–Meier plots depicting the survival distribution of the four tumor types. For Kaplan–Meier plots, the log rank test was used to assess significance. *P < 0.05, **P < 0.005, Student’s t-test. Ad-L = left-side adenocarcinoma (n = 114), Ad-R = right-side adenocarcinoma (n = 71), Mu-L = left-side mucinous adenocarcinoma (n = 14), Mu-R = right-side mucinous adenocarcinoma (n = 19)

References

    1. Lord CJ, Ashworth A. BRCAness revisited. Nat Rev Cancer. 2016;16:110–20. doi: 10.1038/nrc.2015.21. - DOI - PubMed
    1. Kadouri L, Hubert A, Rotenberg Y, et al. Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations. J Med Genet. 2007;44:467–71. doi: 10.1136/jmg.2006.048173. - DOI - PMC - PubMed
    1. Kirchhoff T, Satagopan JM, Kauff ND, et al. Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. J Natl Cancer Inst. 2004;96:68–70. doi: 10.1093/jnci/djh006. - DOI - PubMed
    1. Niell BL, Rennert G, Bonner JD, Almog R, Tomsho LP, Gruber SB. BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst. 2004;96:15–21. doi: 10.1093/jnci/djh008. - DOI - PubMed
    1. van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, et al. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet. 2005;42:711–9. doi: 10.1136/jmg.2004.028829. - DOI - PMC - PubMed